SHMT2 and melanoma: But we were also able to establish links between this A37/Ery+ signature and: (a) immunosuppressive states encountered in melanoma and liver transplant recipients under maintenance therapy; (b) fetal GlyA+ erythroid precursors; and (c) literature attributing immunosuppressive properties of erythroid cells, including in the context of neonatal infections.